# A Study to Assess Bioavailability and Pharmacokinetics of CAT- 354

> **NCT00638989** · PHASE1 · COMPLETED · sponsor: **MedImmune LLC** · enrollment: 30 (actual)

## Conditions studied

- Asthma
- Healthy

## Interventions

- **BIOLOGICAL:** CAT-354 150 mg (intravenous)
- **BIOLOGICAL:** CAT-354 150 mg (subcutaneous)
- **BIOLOGICAL:** CAT-354 300 mg (subcutaneous)

## Key facts

- **NCT ID:** NCT00638989
- **Lead sponsor:** MedImmune LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04-11
- **Primary completion:** 2008-06-07
- **Final completion:** 2008-06-07
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00638989

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00638989, "A Study to Assess Bioavailability and Pharmacokinetics of CAT- 354". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00638989. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*